Alpha 2.0
Login Register
» Authors » Elisabeth J Adams

Elisabeth J Adams

Explore the profile of Elisabeth J Adams including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 37
Citations 631
Followers 0
Related Specialties
General Medicine
Infectious Diseases
Gynecology & Obstetrics
Top 10 Co-Authors
Douglas G Tincello
Georgie Weston
David H Richmond
Anne Meiwald
Abimbola Williams
S Tariq Sadiq
Michael J Harvey
Katherine M E Turner
Caroline Dombrowski
Yixuan Ma
Published In
BMJ Open
Int J Chron Obstruct Pulmon Dis
Sex Transm Infect
BJOG
Cochrane Database Syst Rev
Affiliations
Soon will be listed here.
Recent Articles
1.
Mapping the Common Barriers to Optimal COPD Care in High and Middle-Income Countries: Qualitative Perspectives from Clinicians
Shahaj O, Meiwald A, Puri Sudhir K, Gara-Adams R, Wark P, Cazaux A, et al.
Int J Chron Obstruct Pulmon Dis . 2024 Jun; 19:1207-1223. PMID: 38831892
Purpose: Chronic obstructive pulmonary disease (COPD) poses a significant global health burden despite being largely preventable and treatable. Despite the availability of guidelines, COPD care remains suboptimal in many settings,...
2.
An economic evaluation of two cervical screening algorithms in Belgium: HR-HPV primary compared to HR-HPV and liquid-based cytology co-testing
Dombrowski C, Bourgain C, Ma Y, Meiwald A, Pinsent A, Weynand B, et al.
Eur J Cancer Prev . 2023 Nov; 33(3):262-270. PMID: 37933867
Objective: To assess the costs and benefits of two algorithms for cervical cancer screening in Belgium (1) high-risk human papillomavirus (HR-HPV) primary screening and (2) HR-HPV and liquid-based cytology (LBC)...
3.
Estimating the Health and Economic Impact of Improved Management in Prevalent Chronic Obstructive Pulmonary Disease Populations in England, Germany, Canada, and Japan: A Modelling Study
Adams E, van Doornewaard A, Ma Y, Ahmed N, Cheng M, Watz H, et al.
Int J Chron Obstruct Pulmon Dis . 2023 Oct; 18:2127-2146. PMID: 37789931
Introduction: COPD is a leading cause of morbidity and mortality globally. Management is complex and costly. Although international quality standards for diagnosis and management exist, opportunities remain to improve outcomes,...
4.
Determining the Relationship Between Seizure-Free Days and Other Predictors of Quality of Life in Patients with Dravet Syndrome and Their Carers from FFA Registration Studies
Pinsent A, Weston G, Adams E, Linley W, Hawkins N, Schwenkglenks M, et al.
Neurol Ther . 2023 Jun; 12(5):1593-1606. PMID: 37328668
Introduction: Dravet syndrome (DS) is a rare, lifelong epileptic encephalopathy characterised by frequent and severe seizures associated with premature mortality. Typically diagnosed in infancy, patients also experience progressive behavioural, motor-function...
5.
Two self-sampling strategies for HPV primary cervical cancer screening compared with clinician-collected sampling: an economic evaluation
Huntington S, Puri Sudhir K, Schneider V, Sargent A, Turner K, Crosbie E, et al.
BMJ Open . 2023 Jun; 13(6):e068940. PMID: 37280031
Objective: To compare the costs and effects of three sampling strategies for human papillomavirus (HPV) primary screening. Design: Cost-consequence analysis from a health system perspective using a deterministic decision tree...
6.
The cost-effectiveness of unilateral magnetic resonance-guided focused ultrasound in comparison with unilateral deep brain stimulation for the treatment of medically refractory essential tremor in England
Jameel A, Meiwald A, Bain P, Patel N, Nandi D, Jones B, et al.
Br J Radiol . 2022 Sep; 95(1140):20220137. PMID: 36125247
Objectives: This study aims to ascertain the cost-effectiveness of magnetic resonance-guided focused ultrasound (MRgFUS) for the treatment of medically refractory Essential Tremor (mrET) in England. Essential Tremor (ET) is the...
7.
Health economic evaluation of an mRNA high-risk human papillomavirus (HR-HPV) assay versus a DNA HR-HPV assay for the proposed French cervical screening programme
Dombrowski C, Weston G, Descamps P, Izopet P, Adams E, Adams E
Medicine (Baltimore) . 2022 Jul; 101(29):e29530. PMID: 35866838
Objective: Population screening programmes must make good use of resources for the health system and users. To evaluate impacts of the type of diagnostic test in the new French cervical...
8.
Qualitative Validation of COPD Evidenced Care Pathways in Japan, Canada, England, and Germany: Common Barriers to Optimal COPD Care
Meiwald A, Gara-Adams R, Rowlandson A, Ma Y, Watz H, Ichinose M, et al.
Int J Chron Obstruct Pulmon Dis . 2022 Jul; 17:1507-1521. PMID: 35801119
Background: Chronic obstructive pulmonary disease (COPD) is a major cause of morbidity and mortality worldwide. A comprehensive and detailed understanding of COPD care pathways from pre-diagnosis to acute care is...
9.
A health economic model to estimate the costs and benefits of an mRNA vs DNA high-risk HPV assay in a hypothetical HPV primary screening algorithm in Ontario, Canada
Weston G, Dombrowski C, Steben M, Popadiuk C, Bentley J, Adams E
Prev Med Rep . 2021 Aug; 23:101448. PMID: 34381664
This study models the impact of using two different types of high-risk (HR) human papillomavirus (HPV) tests: mRNA (Aptima) and DNA (Hybrid Capture 2) as part of a hypothetical primary...
10.
Pessaries (mechanical devices) for managing pelvic organ prolapse in women
Bugge C, Adams E, Gopinath D, Stewart F, Dembinsky M, Sobiesuo P, et al.
Cochrane Database Syst Rev . 2020 Nov; 11:CD004010. PMID: 33207004
Background: Pelvic organ prolapse is a common problem in women. About 40% of women will experience prolapse in their lifetime, with the proportion expected to rise in line with an...